🦊/Companies

Data Driven Bioscience

YC S18

Durham, US · Founded 2018 · 10 employees · Hiring · 3 known investors

Find your way into Data Driven Bioscience

128 people in our graph share verified history with the Data Driven Bioscience team — schools, employers, funds. One of them is your warm intro.

Data-Driven Bioscience develops Duoseq, a cancer genomics platform that performs simultaneous DNA and RNA analysis from a single sample, delivering comprehensive molecular profiling results in two days for use in clinical diagnostics and research.

Also known as Data-Driven Bioscience · Duoseq

Founders & leadership· Y Combinator alumni (S18)

Data Driven Bioscience was founded in 2018 by Sandeep Dave.

Investors · 3

Company profile

researched Aug 2026

Data Driven Bioscience is a Durham, North Carolina-based cancer genomics company established in 2018 that builds tools enabling clinical laboratories to apply genomics to the diagnosis and treatment of cancers. Its product, Duoseq, is a next-generation sequencing assay and software suite that prepares and analyzes DNA and RNA together in a single workflow from one sample, producing genomic and transcriptomic information simultaneously rather than requiring separate assays.

The workflow is designed to run entirely on-site at the customer lab: sample preparation and library prep occur on day one, sequencing runs overnight, and a Duoseq Suite report is generated on day two. Beyond mutation calling, the dual DNA/RNA approach reports gene expression, fusions and clonotype data. The company positions the assay for automated, robotic lab workflows requiring under 10 minutes of technician time, and states that Duoseq results integrate directly with EPIC and other electronic health record systems so structured molecular data flows into the patient chart.

Founding story

The company was established in 2018 by Sandeep Dave, who serves as founder and CEO.

Business model

The company supplies an assay and analysis platform to clinical laboratories, which run the Duoseq workflow and sequencing in-house rather than sending specimens to a reference lab.

Traction

Y Combinator lists a team size of 10 and an active status, with the company recruiting a bioinformatics specialist. The company's site publishes anonymous customer testimonials citing in-house comprehensive NGS results obtained faster than shipping samples to outside labs, reduced hospitalization days spent awaiting diagnosis, and MolDX and regulatory support.

Full profile — market position, technology, go-to-market, geography, history

Market position

Positions itself as delivering cancer diagnosis 10 times faster and 10 times cheaper than existing approaches, replacing multiple separate assays and external send-out testing.

Combined DNA and RNA profiling from a single sample and single preparation, on-site execution that avoids shipping specimens to outside labs, a two-day sample-to-report turnaround, low technician hands-on time, and direct EHR/EPIC integration of results.

Technology

Duoseq uses a single all-in-one library preparation that processes DNA and RNA from the same sample in the same prep, coupled with overnight sequencing and the Duoseq Suite reporting software. Outputs include mutations, gene expression, fusions and clonotype information from one assay. The workflow is built for automation and integrates with EPIC and other EHR systems.

Go-to-market

Direct engagement with laboratory and health-system customers via inbound contact from the company website, supported by customer testimonials and stated MolDX and regulatory support for adopters.

Clinical laboratories, hospitals and pathology/oncology groups performing cancer molecular profiling, as well as research users.

Geography

Headquartered at 4711 Hope Valley Rd, Durham, North Carolina, United States; job postings list Durham with remote options.

History

Founded in 2018 in Durham, North Carolina, the company took part in Y Combinator's Summer 2018 batch, where it described its work as making cancer diagnosis 10 times faster and 10 times cheaper. It has since developed and commercialized the Duoseq combined DNA/RNA cancer profiling assay and reporting suite.

Compiled by commissioned research from 4 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Team sizeJan 201810 employees
Technician hands on timeJan 2025under 10 minutes
Turnaround time sample to reportJan 20252 days

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 1

launches, deals, and filings
Jan 2018
Participated in Y Combinator Summer 2018 batch

Data Driven Bioscience is listed as a Y Combinator Summer 2018 batch company, categorized under artificial intelligence, biotech and healthcare, based in Durham, North Carolina.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Research sources · 4

primary sources listed

4 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Data Driven Bioscience do?
Cancer genomics company whose Duoseq assay profiles DNA and RNA from one sample with results in two days.
Who founded Data Driven Bioscience?
Data Driven Bioscience was founded by Sandeep Dave in 2018.
Who are Data Driven Bioscience's investors?
Data Driven Bioscience's investors include HAWKTAIL, Leadout Capital, Y Combinator.
Where is Data Driven Bioscience headquartered?
Data Driven Bioscience is headquartered in Durham, US.